Valerio Therapeutics Shuts Down Trials: What It Means for Cancer Research
Valerio Therapeutics has suspended all clinical trials due to significant financial challenges. The company is pivoting towards early-stage projects while developing a single-chain antibody platform. Financial resources are projected to…